Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer

The addition of lapatinib (Tykerb/Tyverb) to capecitabine (Xeloda) delays disease progression more effectively than capecitabine monotherapy in women with previously treated HER2+ metastatic breast cancer (MBC). The quality-adjusted time without symptoms of disease or toxicity of treatment (Q-TWiST)...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Sherrill, B, Amonkar, M M, Stein, S, Walker, M, Geyer, C, Cameron, D
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2008
Fag:
Clinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2528149/
https://ncbi.nlm.nih.gov/pubmed/18728660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604501
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker